Company Filing History:
Years Active: 2013
Title: James A. Osborn: Innovator in Pharmaceutical Chemistry
Introduction
James A. Osborn is a notable inventor based in Wilmington, Delaware. He has made significant contributions to the field of pharmaceutical chemistry. His work primarily focuses on the development of innovative compounds and formulations.
Latest Patents
James A. Osborn holds a patent for "Crystalline forms - 11-piperazin-1-yldibenzo[b,f][1,4]thiazepine, compositions thereof, preparations thereof, formulations thereof, prodrugs thereof and pharmaceutical uses thereof." This patent highlights his expertise in creating new pharmaceutical compounds that can potentially lead to improved therapeutic outcomes.
Career Highlights
Osborn is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to work on cutting-edge research and development projects. His contributions have been instrumental in advancing the company's pharmaceutical offerings.
Collaborations
James A. Osborn has collaborated with notable colleagues, including Simon Nicholas Black and Simon D. Broady. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.
Conclusion
James A. Osborn's work exemplifies the impact of innovation in pharmaceutical chemistry. His patent and collaborations reflect his commitment to advancing medical science. His contributions continue to shape the future of drug development and therapeutic solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.